Group 1 - The announcement details the pledge and release of shares by the controlling shareholder, Fosun High Technology, which holds approximately 36.00% of the company's total shares as of November 6, 2025 [2][3] - After the pledge and release, the remaining pledged shares by Fosun High Technology amount to 546,925,000 shares, representing about 20.48% of the total shares [2][3] - The total shares held by Fosun High Technology and its concerted parties amount to 967,812,180 shares, which is approximately 36.24% of the company's total shares [2][3] Group 2 - As of November 6, 2025, 36,670,000 pledged shares are expected to mature within the next year, accounting for about 13.73% of the company's total shares, with a corresponding financing balance of RMB 3.431 billion [7] - Fosun High Technology confirms that its operations are normal and it has the ability to repay the financing, with sources including bond issuance and investment returns [7] - The company will closely monitor the progress of the share pledges and fulfill its disclosure obligations as required by laws and regulations [8] Group 3 - The company has scheduled its second extraordinary general meeting for December 2, 2025, with both onsite and online voting options available for shareholders [10][11] - The meeting will be held at Shanghai Tianxi Jiafu Puti Hotel, starting at 13:30 [12] - A detailed voting procedure is provided for A-share shareholders, including registration and voting methods [18][20]
上海复星医药(集团)股份有限公司关于股东部分股份质押及解除质押的公告